Clinical Trial Update: Differences in Endothelial Function Amongst Sitagliptin and Liraglutide Users [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating differences in endothelial function between users of sitagliptin and liraglutide in adults with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Januvia (sitagliptin)
• Victoza (Liraglutide)

Snippet

Sponsor: Anna Cruceta | Conditions: DIABETES Mellitus Type 2 Not Well Controlled | Phase 4 | Status: COMPLETED